Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Lyne Laboratories, Inc.
WARNING LETTER
•Lyne Laboratories, Inc.•October 5, 2007

Lyne Laboratories, Inc. – FDA Warning Letter, Oct 5, 2007

Record Details

On January 17, 2008, the FDA issued a Warning Letter to Lyne Laboratories, Inc. following an inspection from September 20 to October 5, 2007, which revealed significant deviations from CGMP regulations (21 CFR Part 211) for finished pharmaceuticals. These deviations render the firm's products adulterated under Section 501(a)(2)(B) of the Federal Food, Drug, and Cosmetic Act.

Key violations include: 1. **Failure to thoroughly review batch failures (21 CFR § 211.192):** Lyne Laboratories has not completed an investigation into the chemical composition and patient risk of particulate matter in Calcitriol Injection, an issue previously noted in December 2005. The firm continues to observe visible particulates post-100% visual inspection. 2. **Inadequate laboratory controls (21 CFR § 211.160(b)):** The firm's quality control criteria are insufficient to ensure removal of all ampoules with visible particulates or charring. The 100% visual inspection process for Calcitriol product has not been validated to demonstrate its effectiveness in removing defective ampoules.

While the firm's November 6, 2007, response to the FDA-483 acknowledged efforts and committed to revising specifications, the FDA deemed the response unsatisfactory regarding the

Company
Lyne Laboratories, Inc.
Inspection date
October 5, 2007
Product type
Drugs
Office
New England District Office
People
  • Michael R. Kravchuk (Retired Director)
  • Robert Crisafi
View Company Profile

ID · a9d2a39d-dc21-4303-8db6-1708d76a72bb

Violation Codes4
21 U.S.C. 351(a)(2)(B)21 CFR 21121 CFR 211.19221 CFR 211.160(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lyne Laboratories, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.